Yana K. Mangasarova— Head of the Department of Chemotherapy of Lymphatic Tumors with Bone Marrow and Hematopoietic Stem Cell Transplantation Unit with Day Hospital,
Yana Mangasarova graduated from the Faculty of Medicine of the Russian State Medical University of the Federal Agency for Health and Social Development, Moscow (2015). She completed her clinical residency at the Hematological Research Center, staying to work as a hematologist at the NMRC for Hematology. Mangasarova defended her dissertation for the degree of Candidate of Medical Sciences in the specialty 14.01.21 (hematology and blood transfusion) "Molecular diagnostics of primary mediastinal B-large cell lymphoma and diffuse B-large cell lymphoma with primary involvement of mediastinal lymph nodes" (2012).
She was appointed to the position of head of the Day Hospital Department of Intensive High- dose Hemoblastosis Chemotherapy (2019) and transferred to the position of head of the Department of Chemotherapy of Lymphatic Tumors with Bone Marrow and Hematopoietic Stem Cell Transplantation Unit with Day Hospital (2022).
In 2020, she became the winner of the RAKFOND 2020-02 competition with the project "Search for diagnostically significant markers of microsatellite instability with aggressive lymphomas."
She is the author and co-author of more than 140 publications, Russian clinical guidelines for the diagnosis and treatment of lymphoproliferative diseases, and a participant in international and domestic conferences.
Publications
